World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
16148
World Ranking
1942
National Ranking
135

Overview

Gerhard Moldenhauer is affiliated with the German Cancer Research Center in Germany. Their research primarily focuses on the field of Medicine, with significant contributions in various subfields including Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Epidemiology, and Genetics.

Their published work demonstrates engagement with key topics such as Monoclonal and Polyclonal Antibodies Research, Cytokine Signaling Pathways and Interactions, CAR-T cell therapy research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, Virus-based gene therapy research, and Hepatitis C virus research.

Recent notable papers authored or co-authored by Gerhard Moldenhauer include:

  • Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models, 2021, Frontiers in Immunology
  • T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice, 2021, Journal of Hepatology
  • A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1, 2021, European Journal Of Haematology
  • Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma, 2021, European Journal Of Haematology

Gerhard Moldenhauer frequently publishes in the following venues:

  • European Journal Of Haematology
  • Frontiers in Immunology
  • Journal of Hepatology

Collaborative work involves regular co-authorship with researchers such as Marten Meyer, Nadja Bulbuc, Frank Momburg, Stephanie E. Weissinger, and Malena Zahn.

Best Publications

  • Of mice and men: hybridoma and recombinant antibodies

    M Little;S.M Kipriyanov;F Le Gall;G Moldenhauer

  • VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

    B. M. Beckermann;Georgios Kallifatidis;Georgios Kallifatidis;A. Groth;A. Groth;D. Frommhold

  • Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.

    S M Kipriyanov;G Moldenhauer;J Schuhmacher;B Cochlovius

  • Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.

    Anne-Kathleen Rupp;Christian Rupp;Sascha Keller;Jan C. Brase

  • Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling

    Georgios Kallifatidis;Vanessa Rausch;Bernd Baumann;Anja Apel

  • High level production of soluble single chain antibodies in small-scale Escherichia coli cultures

    Sergey M. Kipriyanov;Gerhard Moldenhauer;Melvyn Little

  • HLA-DM Acts as a Molecular Chaperone and Rescues Empty HLA-DR Molecules at Lysosomal pH

    Harald Kropshofer;Sven O Arndt;Gerhard Moldenhauer;Günter J Hämmerling

  • Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.

    Georgios Kallifatidis;Georgios Kallifatidis;Sabrina Labsch;Sabrina Labsch;Vanessa Rausch;Vanessa Rausch;Juergen Mattern;Juergen Mattern

  • Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma

    Gerhard Moldenhauer;Alexei V. Salnikov;Sandra Lüttgau;Ingrid Herr

  • CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.

    A Pezzutto;B Dörken;P S Rabinovitch;J A Ledbetter

  • Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30

    Eva Schlecker;Nathalie Fiegler;Annette Arnold;Peter Altevogt

  • Bispecific CD3 × CD19 diabody for T cell-mediated lysis of malignant human B cells

    Sergey M. Kipriyanov;Gerhard Moldenhauer;Gudrun Strauss;Melvyn Little

  • HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

    B Dörken;G Moldenhauer;A Pezzutto;R Schwartz

  • Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding.

    Fabrice Le Gall;Sergey M. Kipriyanov;Gerhard Moldenhauer;Melvyn Little

  • Efficient Inhibition of Intra-Peritoneal Tumor Growth and Dissemination of Human Ovarian Carcinoma Cells in Nude Mice by Anti-L1-Cell Adhesion Molecule Monoclonal Antibody Treatment

    Matthias J.E. Arlt;Ilse Novak-Hofer;Daniela Gast;Verena Gschwend

  • Dietary polyphenol quercetin targets pancreatic cancer stem cells.

    Wei Zhou;Georgios Kallifatidis;Bernd Baumann;Vanessa Rausch;Vanessa Rausch

  • Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma.

    F Momburg;N Koch;P Möller;G Moldenhauer

  • Dimeric and multimeric antigen binding structure

    Fabrice Le Gall;Sergey Kipriyanov;Uwe Reusch;Gerhard Moldenhauer

  • Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.

    Peter Möller;Peter Möller;Gerhard Moldenhauer;Gerhard Moldenhauer;Frank Momburg;Frank Momburg;Birgit Lämmler;Birgit Lämmler

  • Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.

    G. Moldenhauer;F. Momburg;P. Möller;R. Schwartz

Frequent Co-Authors

Melvyn Little
Melvyn Little German Cancer Research Center
Günter J. Hämmerling
Günter J. Hämmerling German Cancer Research Center
Peter Altevogt
Peter Altevogt German Cancer Research Center
Frank Momburg
Frank Momburg German Cancer Research Center
Annemarie Poustka
Annemarie Poustka German Cancer Research Center
Markus W. Büchler
Markus W. Büchler Champalimaud Foundation
Volker Schirrmacher
Volker Schirrmacher German Cancer Research Center
Bernd Arnold
Bernd Arnold German Cancer Research Center
Adelheid Cerwenka
Adelheid Cerwenka Heidelberg University
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to diverse healthcare and research careers. For many, transitioning within the nursing field complements an immunology background. For instance, experienced nurses interested in specialized patient care can explore the pathway from fnp to acute care np, gaining advanced skills to address critical illnesses.

Students who are eager to fast-track their nursing careers might consider enrolling in a nurse practitioner accelerated program. These programs cater to those seeking efficiency without compromising on quality education, making them ideal for dedicated learners.

For individuals without prior nursing experience but an interest in healthcare, online nursing programs for non nurses provide an accessible starting point. These programs offer flexible learning options that accommodate diverse schedules and career goals.

Applicants seeking a simpler entry into nursing education might explore the easiest accelerated nursing programs to get into. While more accessible, these programs still maintain solid curriculums that prepare students for rewarding careers in healthcare and immunology-related fields.

Best Scientists Citing Gerhard Moldenhauer

Trending Scientists

Recently Published Articles